Kisspeptin-10

Introduction

Kisspeptin-10 represents one of the most significant discoveries in reproductive neuroendocrinology, functioning as the master regulatory peptide that controls the hypothalamic-pituitary-gonadal (HPG) axis and serves as the fundamental gatekeeper of mammalian reproduction. Originally discovered through groundbreaking research spanning 1996 to 2003, this 10-amino acid peptide emerged from investigations into the KISS1 gene—initially identified as a metastasis suppressor—and its orphan G-protein-coupled receptor GPR54 (now known as KISS1R). The pivotal breakthrough occurred in 2003 when researchers identified that mutations in either the KISS1 gene or its receptor resulted in complete failure of pubertal development and lifelong hypogonadotropic hypogonadism, establishing kisspeptin as an essential regulator of mammalian reproductive function. This discovery revolutionized our understanding of reproductive biology by revealing that all reproductive processes—from puberty initiation to fertility maintenance—depend on the proper functioning of the kisspeptin system.

Structurally, Kisspeptin-10 consists of the conserved C-terminal decapeptide sequence (YNWNSFGLRF-NH2) that represents the minimal active fragment capable of full biological activity at the KISS1R receptor. Despite being the shortest member of the kisspeptin family, which includes longer variants of 13 and 54 amino acids, Kisspeptin-10 exhibits equivalent receptor binding affinity (Ki 1.45–2.33 nM) and biological potency to its longer counterparts. The peptide's structure features a critical C-terminal arginine-phenylalanine amide (RFamide) motif essential for high-affinity receptor binding, while its N-terminal region adopts a helicoidal conformation that facilitates optimal receptor interaction. This molecular architecture enables Kisspeptin-10 to function as a potent activator of GnRH neurons, the hypothalamic cells responsible for initiating the hormonal cascade that controls reproductive function throughout the lifespan.

The research significance of Kisspeptin-10 extends far beyond its reproductive roles to encompass metabolic regulation, cardiovascular function, and neuroendocrine integration. Research demonstrates that kisspeptin neurons serve as sophisticated metabolic sensors, integrating energy status with reproductive capacity through complex neuronal networks in the hypothalamus. These neurons co-express neurokinin B and dynorphin in specialized KNDy networks that generate the pulsatile GnRH secretion patterns essential for normal reproductive function. Additionally, kisspeptin receptors are expressed throughout peripheral tissues including adipose tissue, liver, pancreas, and cardiovascular system, suggesting multisystem regulatory functions that position this peptide as a central coordinator of energy homeostasis and reproductive capacity. Research investigations have explored Kisspeptin-10's mechanisms in reproductive biology, demonstrating its ability to safely induce ovulation during IVF procedures while reducing the risk of ovarian hyperstimulation syndrome, highlighting its promise as both a research tool and potential therapeutic agent for reproductive disorders.

KISS1R Receptor Signaling and Molecular Mechanisms

The biological effects of Kisspeptin-10 are mediated through its high-affinity interaction with the KISS1R (GPR54) receptor, a rhodopsin-family G-protein-coupled receptor that exhibits sophisticated signaling capabilities recently elucidated through breakthrough cryo-electron microscopy studies. KISS1R predominantly couples to Gq/11 proteins, though recent structural analysis by Wu et al. (2024) revealed the receptor's capacity for dual coupling to both Gq/11 and Gi/o pathways, expanding our understanding of kisspeptin's signaling versatility. Upon Kisspeptin-10 binding, the receptor undergoes conformational changes that activate phospholipase C (PLC), leading to the hydrolysis of phosphatidylinositol 4,5-bisphosphate (PIP2) into inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG). This classical Gq/11 signaling cascade generates rapid increases in intracellular calcium through IP3-mediated release from endoplasmic reticulum stores, while DAG activates protein kinase C (PKC), creating a coordinated signaling response that underlies kisspeptin's diverse biological effects.

The intracellular signaling networks activated by Kisspeptin-10 extend beyond classical second messenger pathways to encompass sophisticated mitogen-activated protein kinase (MAPK) cascades that regulate gene expression and cellular responses. PKC activation leads to strong, sustained phosphorylation of extracellular signal-regulated kinases 1 and 2 (ERK1/2), which translocate to the nucleus to phosphorylate transcription factors including CREB and c-Fos, ultimately modulating the expression of genes involved in cellular excitability and hormone secretion. Additionally, Kisspeptin-10 activates p38 MAPK pathways, though with lower intensity than ERK1/2, and modulates β-arrestin signaling that regulates receptor desensitization and internalization. Research demonstrates that β-arrestin-1 decreases ERK1/2 phosphorylation while β-arrestin-2 enhances it, revealing complex regulatory mechanisms that fine-tune cellular responses to kisspeptin stimulation and prevent excessive receptor activation.

The temporal dynamics of KISS1R signaling involve sophisticated desensitization mechanisms that are critical for understanding Kisspeptin-10's pharmacological properties and research applications. Continuous exposure to kisspeptin causes rapid receptor desensitization through β-arrestin-mediated receptor internalization and downregulation, leading to paradoxical suppression of GnRH neuron activity and subsequent HPG axis inhibition. This phenomenon explains why chronic, high-dose kisspeptin administration can suppress rather than stimulate reproductive function, a finding with important implications for therapeutic dosing strategies. Laboratory studies reveal that receptor resensitization occurs within 4-6 hours following kisspeptin washout, suggesting that intermittent dosing protocols may be optimal for maintaining receptor responsiveness. These pharmacodynamic properties have been leveraged in clinical applications, where carefully timed kisspeptin administration can either stimulate reproductive function (through acute dosing) or temporarily suppress it (through continuous administration), demonstrating the peptide's versatility as a research tool for investigating reproductive physiology.

Hypothalamic-Pituitary-Gonadal Axis Regulation

Kisspeptin-10's most fundamental biological role involves its function as the master regulator of the hypothalamic-pituitary-gonadal (HPG) axis, the neuroendocrine system that controls all aspects of reproductive function from puberty through senescence. The peptide exerts its effects primarily through direct stimulation of GnRH neurons in the hypothalamus, specialized cells that synthesize and release gonadotropin-releasing hormone (GnRH) in precise pulsatile patterns essential for normal reproductive function. Kisspeptin neurons make direct synaptic contacts with GnRH neurons and express the molecular machinery necessary for rapid excitatory neurotransmission, including glutamate and GABA systems. When Kisspeptin-10 binds to KISS1R receptors on GnRH neurons, it triggers immediate membrane depolarization through inhibition of inwardly rectifying potassium channels (Kir) and activation of nonselective cation channels (TRPC), resulting in increased action potential firing and enhanced GnRH release into the hypothalamic-hypophyseal portal circulation.

The neuroanatomical organization of kisspeptin neurons reveals sophisticated regulatory networks that integrate multiple physiological signals to coordinate reproductive function with metabolic status and environmental conditions. Two major populations of kisspeptin neurons exist in the mammalian hypothalamus: the KNDy neurons in the arcuate nucleus (ARC) that co-express neurokinin B (NKB) and dynorphin (Dyn), and the kisspeptin neurons in the anteroventral periventricular nucleus (AVPV) that are critical for the preovulatory LH surge. The KNDy neuronal network functions as a sophisticated pulse generator, where NKB stimulates kisspeptin release to initiate GnRH pulses, while dynorphin subsequently inhibits kisspeptin neurons to terminate each pulse, creating the rhythmic GnRH secretion patterns necessary for appropriate gonadotropin release. Research demonstrates that disruption of any component of the KNDy system—whether through genetic mutations, hormonal imbalances, or metabolic stress—can profoundly alter reproductive function, highlighting the critical importance of this neuronal network in reproductive physiology.

Clinical and experimental evidence demonstrates that Kisspeptin-10 administration can rapidly and potently stimulate LH and FSH secretion in humans and animal models, with effects observable within minutes of administration. Research studies demonstrate that Kisspeptin-10 administration can modulate LH levels in experimental models, with effects observable within minutes, representing a 3-fold increase that rivals or exceeds the response to synthetic GnRH administration. The dose-response relationship for kisspeptin-induced LH release follows a sigmoidal curve, with maximal responses achieved at doses of 3-10 μg/kg in most subjects. Importantly, the gonadotropin response to Kisspeptin-10 is preserved in conditions where GnRH neurons remain functional but are suppressed by negative feedback, such as during hormonal contraception or gonadal steroid administration, suggesting that kisspeptin can override some forms of reproductive axis suppression and providing insights into the hierarchical organization of reproductive control mechanisms.

Puberty Regulation and Developmental Biology

The role of Kisspeptin-10 in puberty regulation represents one of the most clinically significant aspects of its biology, as this peptide system controls the timing and progression of sexual maturation in mammals. Puberty onset is initiated by the reactivation of GnRH neurons following a period of relative quiescence during childhood, and research has definitively established that increased kisspeptin signaling is the primary trigger for this developmental transition. During prepubertal development, kisspeptin neurons remain relatively inactive due to high sensitivity to sex steroid negative feedback and the influence of inhibitory factors including GABA and various epigenetic mechanisms. As organisms approach pubertal age, decreasing sensitivity to steroid inhibition combined with increasing excitatory inputs leads to enhanced kisspeptin neuron activity, which in turn stimulates GnRH neurons and initiates the cascade of hormonal changes that characterize pubertal development.

Genetic studies have provided compelling evidence for kisspeptin's essential role in puberty by identifying animal models with inactivating mutations in either the KISS1 gene or the KISS1R receptor that fail to undergo spontaneous pubertal development. These models present with hypogonadotropic hypogonadism, characterized by absent or incomplete sexual development, low gonadotropin levels, and infertility. Conversely, animal models with activating mutations in KISS1R develop central precocious puberty, with early onset of sexual development. These research observations demonstrate that the kisspeptin system functions as a critical regulatory switch for pubertal timing in experimental models, with both deficient and excessive signaling leading to alterations in sexual development.

Research into the molecular mechanisms controlling pubertal kisspeptin activation reveals complex interactions between genetic, epigenetic, and environmental factors that determine the timing of sexual maturation. The transcriptional regulation of the KISS1 gene involves multiple regulatory elements that respond to developmental signals, metabolic status, and photoperiodic cues. Epigenetic modifications, particularly DNA methylation and histone modifications, play crucial roles in silencing KISS1 expression during childhood and permitting its reactivation at puberty. Additionally, microRNAs including miR-200 and miR-155 regulate kisspeptin expression post-transcriptionally, adding another layer of control to pubertal timing. Environmental factors such as nutrition, stress, and exposure to endocrine disruptors can alter these regulatory mechanisms, explaining how external conditions can influence pubertal timing. Laboratory studies demonstrate that Kisspeptin-10 administration can advance pubertal onset in prepubertal animals, while kisspeptin antagonists can delay it, providing powerful tools for investigating the mechanisms that control developmental timing and sexual maturation.

Metabolic Integration and Energy Balance

Kisspeptin-10's role in metabolic regulation represents a sophisticated biological mechanism that integrates reproductive function with energy availability, ensuring that reproduction occurs only when sufficient metabolic resources are available to support successful pregnancy and offspring survival. Kisspeptin neurons throughout the hypothalamus express receptors for key metabolic hormones including leptin, insulin, and ghrelin, positioning them as central sensors of nutritional status. Research demonstrates that kisspeptin neurons are directly responsive to glucose availability, with low glucose conditions suppressing kisspeptin gene expression and peptide release, while restored glucose availability rapidly reactivates the system. This metabolic sensing capability explains the well-documented clinical observation that severe caloric restriction, such as that seen in anorexia nervosa or intensive athletic training, can suppress reproductive function through inhibition of the kisspeptin-GnRH axis.

The neuroanatomical connections between kisspeptin neurons and established metabolic regulatory circuits reveal sophisticated mechanisms for coordinating energy balance with reproductive capacity. Kisspeptin neurons in the arcuate nucleus are anatomically linked to and can directly excite anorexigenic POMC neurons that suppress appetite, while indirectly inhibiting orexigenic NPY/AgRP neurons that stimulate feeding behavior. Additionally, kisspeptin neurons receive direct inputs from leptin-responsive neurons and express leptin receptors themselves, enabling them to integrate information about adipose tissue energy stores with reproductive status. Research shows that leptin-deficient mice (ob/ob) have suppressed kisspeptin expression and fail to undergo normal pubertal development, while leptin replacement restores both kisspeptin signaling and reproductive function, demonstrating the critical importance of adequate energy stores for reproductive activation.

Recent research investigations have explored the direct metabolic effects of Kisspeptin-10 administration in experimental models, revealing complex interactions that extend beyond reproductive physiology to influence energy homeostasis and metabolic function. Research in animal models examined the effects of intravenous kisspeptin-54 (1 nmol/kg/h over 2 hours) on appetite and food intake parameters, finding that acute administration effects vary across experimental conditions. Peripheral expression of KISS1 and KISS1R in metabolically active tissues including white and brown adipose tissue, liver, and pancreatic islets suggests that chronic kisspeptin signaling may influence metabolic function through direct tissue effects rather than central appetite regulation. Laboratory studies in rodent models demonstrate that kisspeptin administration can improve glucose tolerance and insulin sensitivity, while also affecting lipid metabolism and thermogenesis in brown adipose tissue, indicating potential applications for metabolic research that warrant further investigation in appropriate experimental contexts.

Cardiovascular and Vascular Research Applications

The cardiovascular effects of Kisspeptin-10 represent an emerging area of research that highlights the peptide's potential beyond reproductive physiology, with growing evidence for direct actions on cardiac function and vascular biology. KISS1R receptors are expressed in multiple cardiovascular tissues including cardiomyocytes, vascular smooth muscle cells, and endothelial cells of both coronary and peripheral blood vessels. In the heart, kisspeptin demonstrates direct inotropic effects, with research showing that Kisspeptin-10 administration increases cardiac contractility through KISS1R-mediated mechanisms that involve calcium mobilization and enhanced myofilament sensitivity. These cardiac effects are independent of changes in heart rate or blood pressure, suggesting specific actions on myocardial contractile function that could have implications for understanding cardiac physiology and developing research models of heart function.

Vascular research reveals that kisspeptin signaling influences multiple aspects of blood vessel function including vasodilation, angiogenesis, and endothelial cell survival. Endothelial cells express both KISS1 and KISS1R, suggesting autocrine and paracrine regulatory mechanisms that may contribute to vascular homeostasis. Research demonstrates that Kisspeptin-10 can stimulate endothelial nitric oxide synthase (eNOS) activity, leading to increased nitric oxide production and endothelium-dependent vasodilation in both resistance and capacitance vessels. Additionally, kisspeptin administration enhances endothelial cell proliferation and migration in vitro, while promoting angiogenesis in experimental models of vascular injury or ischemia. These pro-angiogenic effects involve activation of VEGF signaling pathways and enhanced expression of endothelial growth factors, suggesting potential applications in research investigating vascular repair and regeneration mechanisms.

Clinical cardiovascular research has begun to explore the therapeutic potential of kisspeptin in various cardiovascular conditions, though these applications remain in early investigational phases. Studies in animal models of myocardial infarction demonstrate that kisspeptin administration can reduce infarct size and improve cardiac function recovery through mechanisms involving enhanced angiogenesis, reduced cardiomyocyte apoptosis, and improved endothelial function. Research in models of hypertension suggests that chronic kisspeptin signaling may help maintain endothelial function and reduce vascular inflammation, potentially through antioxidant mechanisms and improved endothelial nitric oxide bioavailability. While these cardiovascular effects of Kisspeptin-10 show promise for research applications, it is important to note that all such studies remain in experimental phases and require extensive further investigation before any potential research applications could be considered. The peptide's cardiovascular research applications are particularly valuable for investigating the intersection between reproductive hormones and cardiovascular health, as well as for developing novel experimental models of vascular function and cardiac physiology.

Neuroendocrine Integration and Behavioral Research

The neuroendocrine effects of Kisspeptin-10 extend throughout the central nervous system, where it functions as a critical integrator of multiple hormonal and neuronal signals that coordinate reproductive behavior, mood regulation, and stress responses. Beyond its primary role in activating GnRH neurons, kisspeptin signaling influences the hypothalamic-pituitary-adrenal (HPA) axis, with research demonstrating that kisspeptin neurons express receptors for cortisol and other stress hormones that modulate their activity. During periods of acute or chronic stress, elevated glucocorticoid levels suppress kisspeptin gene expression and peptide release, providing a mechanism by which stress can inhibit reproductive function. This neuroendocrine cross-talk explains the clinical observation that psychological stress can disrupt menstrual cycles and fertility, while also highlighting kisspeptin's role as a central coordinator of stress and reproductive responses.

Behavioral research reveals that Kisspeptin-10 influences multiple aspects of mood, motivation, and social behavior through its actions on limbic brain regions including the amygdala, hippocampus, and reward circuitry. Clinical neuroimaging studies using functional magnetic resonance imaging (fMRI) demonstrate that kisspeptin administration increases activity in limbic brain regions associated with sexual and emotional processing, including enhanced activation of the posterior cingulate cortex, thalamus, and hypothalamus. These effects correlate with subjective reports of improved mood, increased sexual motivation, and enhanced overall well-being in study participants. Additionally, kisspeptin administration influences reward-seeking behavior and motivation, with research showing increased activity in dopaminergic reward pathways and enhanced responses to positive emotional stimuli.

The molecular mechanisms underlying kisspeptin's behavioral effects involve complex interactions with multiple neurotransmitter systems including dopamine, serotonin, and GABA networks that regulate mood and behavior. Kisspeptin neurons form synaptic connections with dopaminergic neurons in the ventral tegmental area (VTA) and substantia nigra, brain regions that are critical for motivation, reward processing, and motor control. Research demonstrates that Kisspeptin-10 can enhance dopamine release in key brain regions and potentiate dopaminergic signaling, effects that may contribute to its mood-enhancing and motivational properties. Additionally, kisspeptin signaling interacts with serotonergic pathways involved in mood regulation and stress responses, with studies showing that kisspeptin administration can normalize serotonin levels in animal models of depression and anxiety. These neuroendocrine and behavioral effects position Kisspeptin-10 as a valuable research tool for investigating the complex relationships between reproductive hormones, mood regulation, and behavior, particularly in contexts where understanding the integration of reproductive and emotional processes is important for advancing scientific knowledge.

Clinical Research Applications and Therapeutic Development

The research applications of Kisspeptin-10 have advanced significantly since its discovery, with multiple investigations in animal models demonstrating its effects on reproductive physiology. Research in reproductive biology has examined controlled ovarian stimulation mechanisms in mammalian models, where kisspeptin serves as an experimental tool for investigating gonadotropin surges and oocyte maturation processes. Laboratory studies in animal models demonstrate that kisspeptin-based protocols can modulate ovulation timing and magnitude in experimental systems. Research investigations have explored reproductive mechanisms in controlled laboratory studies, demonstrating effects of precisely controlled kisspeptin administration in research models.

Research studies have demonstrated favorable safety profiles in experimental investigations utilizing various dosing protocols in animal models. Safety assessments in preclinical research show good tolerability across multiple species and dosing regimens. Comprehensive toxicology studies in laboratory animal models demonstrate minimal adverse effects at research-relevant doses, supporting the compound's utility for investigating reproductive and neuroendocrine mechanisms in controlled laboratory settings.

Emerging clinical research applications for Kisspeptin-10 extend beyond reproductive medicine to include investigations in metabolic disorders, mood regulation, and aging research. Clinical trials are currently exploring kisspeptin's potential for treating hypothalamic amenorrhea, a condition characterized by stress-induced suppression of reproductive function that affects many women with eating disorders, excessive exercise, or psychological stress. Preliminary results suggest that carefully designed kisspeptin administration protocols can restore normal menstrual cycles and fertility in some women with functional hypothalamic amenorrhea, though optimal dosing and administration duration remain under investigation. Additionally, research is exploring kisspeptin's potential applications in male hypogonadism, polycystic ovary syndrome (PCOS), and menopausal symptom management, though these applications remain in early clinical development phases. The peptide's effects on mood and behavior have also sparked interest in potential neuropsychiatric applications, with preliminary studies suggesting that kisspeptin may have antidepressant and anxiolytic properties that warrant further investigation in appropriate clinical research contexts.

Conclusion

Kisspeptin-10 stands as a remarkable testament to the power of modern molecular endocrinology, representing a fundamental breakthrough in our understanding of reproductive biology that has revolutionized both basic science and clinical medicine. From its discovery as a product of the KISS1 metastasis suppressor gene to its identification as the master regulator of mammalian reproduction, this 10-amino acid peptide has revealed the sophisticated mechanisms by which nature coordinates reproductive function with metabolic status, stress responses, and overall physiological homeostasis. The peptide's ability to serve as the ultimate upstream controller of the hypothalamic-pituitary-gonadal axis, while simultaneously integrating signals from multiple organ systems, positions it as one of the most important regulatory molecules in mammalian physiology. Through more than two decades of intensive research, Kisspeptin-10 has demonstrated consistent biological activity across species and experimental systems, establishing itself as both a powerful research tool and a promising therapeutic agent for various reproductive and metabolic disorders.

The comprehensive body of research on Kisspeptin-10 provides an exceptional foundation for its continued investigation as a research tool for studying neuroendocrine function, reproductive biology, and metabolic regulation. Its well-characterized receptor interactions, documented safety profile in clinical trials, and sophisticated mechanisms of action make it invaluable for researchers exploring fundamental questions about puberty, fertility, aging, and the integration of reproductive and metabolic systems. The peptide's unique ability to rapidly and potently activate the reproductive axis while influencing mood, behavior, and cardiovascular function offers unprecedented opportunities for advancing our understanding of how hormonal systems coordinate complex physiological processes. As research techniques continue to advance and our knowledge of kisspeptin biology deepens, this peptide will undoubtedly remain at the forefront of endocrinological research, providing insights into fundamental questions about development, reproduction, and the molecular basis of hormonal regulation that will continue to advance scientific knowledge and potentially lead to new therapeutic approaches for reproductive and metabolic disorders.

References

1. Ohtaki, T. et al. (2001). Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein-coupled receptor. Nature 411(6837):613-617. [doi.org]
2. de Roux, N. et al. (2003). Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54. Proceedings of the National Academy of Sciences 100(19):10972-10976. [doi.org]
3. Seminara, S.B. et al. (2003). The GPR54 gene as a regulator of puberty. New England Journal of Medicine 349(17):1614-1627. [doi.org]
4. Wu, Z. et al. (2024). Structural insights into kisspeptin receptor signaling. Nature Structural and Molecular Biology 31(4):567-576. [doi.org]
5. Dhillo, W.S. et al. (2005). Kisspeptin-54 stimulates the hypothalamic-pituitary gonadal axis in human males. Journal of Clinical Endocrinology and Metabolism 90(12):6609-6615. [doi.org]
6. Jayasena, C.N. et al. (2014). Kisspeptin-54 triggers egg maturation in women undergoing in vitro fertilization. Journal of Clinical Investigation 124(8):3667-3677. [doi.org]
7. Abbara, A. et al. (2018). Kisspeptin receptor agonist has therapeutic potential for female reproductive disorders. Journal of Clinical Investigation 128(12):5206-5219. [doi.org]
8. Gottsch, M.L. et al. (2004). A role for kisspeptins in the regulation of gonadotropin secretion in the mouse. Endocrinology 145(9):4073-4077. [doi.org]
9. Smith, J.T. et al. (2005). KiSS-1 neurons in the forebrain as central processors for generating the preovulatory luteinizing hormone surge. Journal of Neuroscience 25(30):6687-6694. [doi.org]
10. Oakley, A.E. et al. (2009). Kisspeptin signaling in the brain. Endocrine Reviews 30(6):713-743. [doi.org]
11. Castellano, J.M. et al. (2005). Pubertal onset and reproductive function in KiSS-1 receptor null mice. Endocrinology 147(5):2166-2174. [doi.org]
12. Luque, R.M. et al. (2007). Kisspeptin regulates gonadotroph and somatotroph function in nonhuman primate pituitary via common and distinct signaling mechanisms. Endocrinology 148(10):4849-4856. [doi.org]
13. Brown, R.E. et al. (2008). Kisspeptin/GPR54 signaling in the hypothalamic regulation of homeostasis. Physiology and Behavior 93(4-5):807-816. [doi.org]
14. Clarkson, J. et al. (2008). Definition of the hypothalamic GnRH pulse generator in mice. Proceedings of the National Academy of Sciences 105(52):20632-20637. [doi.org]
15. Lehman, M.N. et al. (2010). Kisspeptin/neurokinin B/dynorphin (KNDy) cells of the arcuate nucleus: a central node in the control of gonadotropin-releasing hormone secretion. Endocrinology 151(8):3479-3489. [doi.org]
16. Messager, S. et al. (2005). Kisspeptin directly stimulates gonadotropin-releasing hormone release via G protein-coupled receptor 54. Proceedings of the National Academy of Sciences 102(5):1761-1766. [doi.org]
17. Teles, M.G. et al. (2008). A GPR54-activating mutation in a patient with central precocious puberty. New England Journal of Medicine 358(7):709-715. [doi.org]
18. George, J.T. et al. (2011). Kisspeptin-10 is a potent stimulator of LH and increases pulse frequency in men. Journal of Clinical Endocrinology and Metabolism 96(8):E1228-E1236. [doi.org]
19. Skorupskaite, K. et al. (2018). Kisspeptin and neurokinin B interactions in modulating gonadotropin secretion in women with polycystic ovary syndrome. Human Reproduction 35(6):1421-1431. [doi.org]
20. Narayanaswamy, S. et al. (2016). The clinical potential of kisspeptin in the administration of hypogonadism. Therapeutic Advances in Endocrinology and Metabolism 7(4):171-185. [doi.org]
21. Comninos, A.N. et al. (2017). Kisspeptin modulates sexual and emotional brain processing in humans. Journal of Clinical Investigation 127(2):709-719. [doi.org]
22. Yang, L. et al. (2023). Metabolic effects of kisspeptin in obesity research. Endocrinology and Metabolism 38(2):123-135. [doi.org]